ICY:FRA
Incyte Corp
€108.10
arrow_downward
-0.23%(-0.25) 1D
Nov 18, 10:00:00 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ICY...
Open
€108.10
High
€108.10
Low
€108.10
Mkt. cap
24.01B
Avg. vol.
66.00
Volume
0.00
52-wk high
€115.40
52-wk low
€77.60
No. of employees
3K
Open
€108.10
High
€108.10
Low
€108.10
Mkt. cap
24.01B
Avg. vol.
66.00
Volume
0.00
52-wk high
€115.40
52-wk low
€77.60
No. of employees
3K
News stories
From web sources and news partners
Investing.com UK
·
3 hours ago
Damora at Jefferies Global Healthcare Conference: CALR push By Investing.com
www.marketscreener.com
·
1 day ago
Incyte Insider Sold Shares Worth $1,292,032, According to a Recent SEC Filing
Investing.com
·
1 day ago
Incyte at UBS Global Biopharma Conference 2026: growth beyond Jakafi
Investing.com
·
1 day ago
Jefferies reiterates Hold on Incyte stock with $115 price target
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2.84K
Founded2002
HeadquartersWilmington, Delaware, United States
SectorHealth Care
IndustryBiotechnology
Websiteincyte.com